"memo – magazine of european medical oncology"was founded in 2008 by Springer Verlag Wien in cooperation with Prof. Wolfgang Hilbe who since then serves as Editor in Chief.
The focus of the journal is to offer a professional review on current research and development in the field
of hematology and oncology relevant for daily practice. Therefore, “memo” includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles
explaining the biology of neoplasia and congress reports including qualified comments. As a European
journal “memo” aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.
memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and
The Austrian Society of Haematology and Oncology (OeGHO).
The ‘Let’s Collaborate’ initiative launched by Boehringer Ingelheim in Oncology is the guiding ethos directing the company’s commitment to oncology and to improving the future of cancer patients. This principle recognises that collaboration is fundamental to making a difference to patients’ lives. Working together connects, potentiates and enhances ideas, research and education.Against this backdrop, we are pleased to sponsor the memo SPECIAL ISSUEseries, a congress resource for specialists in oncology and haematology that is produced by Springer, the renowned international publisher of specialist scientific information.
We hope you will find the memo Special ISSUE reports a useful and interesting read. As a companion piece to each report, you will also find video interviews with the cancer experts who have contributed to the report, and there are links to other educational resources for you to explore.
We hope you enjoy the website.
This website is intended only for healthcare professionals outside the US, the UK, Australia and Canada
Available for FREE.
memo SPECIAL ISSUES offer
Looking for memo onclick here
Further educational resources
can be found at Boehringer Ingelheim’s dedicated oncology site: inoncology.com